Empowered Funds’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
Other funds holding PLX
Empowered Funds's PLX Position: Q3 2026 in Review
Empowered Funds opened a new position in Protalix BioTherapeutics (PLX) in Q3 2026: 98,344 shares worth $271K. The stake represents ﹤0.01% of the portfolio and ranks #2089 among its holdings.
107 funds tracked by Wall St. Rank hold PLX as of Q3 2026.
- Empowered Funds held 98,344 shares of Protalix BioTherapeutics worth $271K as of Q3 2026.
- Protalix BioTherapeutics was a new Empowered Funds position in Q3 2026.
- Protalix BioTherapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2089 holding.
- 107 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q3 2026.
Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.